Researchers might have developed an Ebola vaccine in time to stem the current outbreak if it weren’t for budget cuts, a top federal health official said in a new interview.
Francis Collins, the head of the National Institutes of Health, said the agency has been working on Ebola vaccines since 2001. “It’s not like we suddenly woke up and thought, ‘Oh my gosh, we should have something ready here,'” Collins told the Huffington Post. “Frankly, if we had not gone through our 10-year slide in research support, we probably would have had a vaccine in time for this that would’ve gone through clinical trials and would have been ready.”
Collins said researchers and doctors would likely have been “a year or two ahead of where we are” had research funding stayed on track.
His comments come as officials are dealing with the second case of the deadly disease to be diagnosed in the United States The death toll from the outbreak, which has ravaged countries in West Africa, recently surpassed 4,000.
Read next: 5 Ways U.S. Hospitals Need to Get Ready For Ebola
More Must-Reads from TIME
- Why Trump’s Message Worked on Latino Men
- What Trump’s Win Could Mean for Housing
- The 100 Must-Read Books of 2024
- Sleep Doctors Share the 1 Tip That’s Changed Their Lives
- Column: Let’s Bring Back Romance
- What It’s Like to Have Long COVID As a Kid
- FX’s Say Nothing Is the Must-Watch Political Thriller of 2024
- Merle Bombardieri Is Helping People Make the Baby Decision
Contact us at letters@time.com